TuHURA Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -23 | -21 | ||
EBITDA | -7,485 | -6,130 | -7,064 | -9,510 |
EBIT | -7,508 | -6,152 | -7,085 | -9,523 |
Net Income | -7,536 | -6,769 | -7,102 | -9,523 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -4,461 | -5,583 | -11,086 | -6,253 |
Cash | 6,298 | 3,619 | 2,697 | 8,512 |
Basic Shares | 60,010 | 47,927 | 50,666 | 44,555 |
Annual Financials
| Values in thousands | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -116 | -55 | -60 | |
EBITDA | -29,355 | -17,427 | -8,265 | -14,589 |
EBIT | -29,426 | -17,544 | -8,320 | -14,649 |
Net Income | -30,060 | -21,682 | -8,320 | -14,649 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,705 | -14,786 | -12,030 | -7,544 |
Cash | 3,619 | 12,657 | 3,665 | 14,252 |
Basic Shares | 47,927 | 18,662 | 752 | 46 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.13 |
2025-12-31 | -$0.16 |
2025-09-30 | -$0.14 |
2025-06-30 | -$0.21 |